Bear killed in North Canaan: CSP
NORTH CANAAN, Conn. (WTNH) — A bear was killed Wednesday at a residence on Greene Road in North Canaan, state police said.
Troopers responded to a call for a bear that had entered the home at approximately 12:53 a.m.
The bear was killed by troopers near the entrance to the building and a second bear fled into the woods.
Beware of bears: They will be wandering through Connecticut soon
DEEP was contacted to properly remove the bear.
Current DEEP policy allows euthanasia as a response to a bear entering a residence.
The homeowner is legally allowed to take the same action under Public Act 23-77.
The number of bear-human interactions has increased over the past few years, according to DEEP.
DEEP advises the public to store trash in bear-proof containers, remove bird feeders and to supervise pets and animals outside.
More information can be found on the department's website.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
14 minutes ago
- Yahoo
HistoSonics Completes Enrollment in #HOPE4KIDNEY Trial Evaluating Non-Invasive Histotripsy to Treat Kidney Tumors
Pivotal Study Advances to Establish Histotripsy as a Non-Thermal, Surgery-Free Alternative to Destroy and Liquefy Kidney Tumors MINNEAPOLIS, June 06, 2025--(BUSINESS WIRE)--HistoSonics, Inc., the manufacturer of the Edison® Histotripsy System and novel histotripsy therapy platforms, today announced the completion of patient enrollment in its pivotal #HOPE4KIDNEY trial. This prospective, multi-center, single-arm trial is designed to evaluate the safety and effectiveness of the Edison System in destroying kidney tissue by treating primary solid kidney tumors. The trial enrolled patients with a single, non-metastatic solid kidney mass ≤3 cm, confirmed by imaging and biopsy. Subjects will be followed for five years post-procedure, with evaluations at multiple time points, including 14-day, 30-day, 90-day, 180-day, and annual assessments. The Edison System remains in investigational use for kidney applications and is not yet FDA-approved for this indication. Data from the #HOPE4KIDNEY trial is expected to support a future submission for regulatory clearance to expand the use of histotripsy to treat kidney tissue/tumors. The Edison System is the first and only platform to use histotripsy, a non-thermal, non-invasive focused ultrasound technology, to mechanically liquefy tumors without surgery, radiation, or systemic therapies. Unlike invasive surgical approaches, histotripsy does not require incisions and enables real-time imaging and treatment monitoring, allowing physicians to target and control tissue destruction while sparing surrounding structures. "Our vision is for the Edison System to become a foundational, non-invasive solution across a wide range of clinical applications," said Mike Blue, President and CEO, HistoSonics. "Completing enrollment in our pivotal kidney tumor trial represents a significant milestone toward that goal and reinforces our confidence in expanding histotripsy into additional tumor types and indications. This achievement reflects the dedication of our team and clinical partners and brings us closer to transforming the treatment of solid tumors without the need for surgery." Dr. William C. Huang, MD FACS, Professor and Vice Chair of Urology at the NYU Grossman School of Medicine serves as a principal investigator at the NYU Langone Medical Center, the top enrolling site in the trial. Dr. Huang commented, "Histotripsy offers a novel, completely non-invasive treatment paradigm for kidney tumors that precisely images and treats tumors while preserving surrounding critical structures thereby minimizing the morbidity associated with traditional surgical and thermal ablative techniques." Dr. Michael McDonald, Assistant Professor of Urology at the University of Central Florida College of Medicine and Urologic Surgeon at AdventHealth at Celebration Florida, serves as a principal investigator for one of the participating sites in the trial. Dr. McDonald commented, "HistoSonics represents a paradigm shift proving that the most profound treatments for both benign and malignant diseases need not be the most invasive. The ability to precisely target and destroy tumors without scalpel or scar is the next step in the evolution of non-surgical intervention." The Edison System has not been evaluated for the treatment of any specific disease, including, but not limited to, cancer or evaluated any specific cancer outcomes (such as local tumour progression, 5-year survival or overall survival). United States Intended Use Statement: The Edison System is intended for the non-invasive mechanical destruction of liver tumors, including the partial or complete destruction of unresectable liver tumors via histotripsy. The FDA has not evaluated the Edison System for the treatment of any disease including, but not limited to, cancer or evaluated any specific cancer outcomes (such as local tumor progression, 5-year survival or overall survival). The System should only be used by physicians who have completed training performed by HistoSonics, and its use guided by the clinical judgment of an appropriately trained physician. Refer to the device Instructions for Use for a complete list of warnings, precautions, and a summary of clinical trial results, including reported adverse events. About HistoSonics HistoSonics is a privately held medical device company developing a non-invasive platform and proprietary sonic beam therapy utilizing the science of histotripsy, a novel mechanism of action that uses focused ultrasound to mechanically destroy and liquify unwanted tissue and tumors. The company is currently focused on commercializing their Edison System in the US and select global markets for liver treatment while expanding histotripsy applications into other organs like kidney, pancreas, prostate, and others. HistoSonics has offices in Ann Arbor, Michigan and Minneapolis, MN. For more information on the Edison Histotripsy System please visit: For patient-related information please visit: View source version on Contacts Media contacts:Josh KingVice President of 608.332.8124 Kimberly HaKKH Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
22 minutes ago
- Yahoo
Teen allegedly shows off imitation gun to officers at Jones Beach: NCPD
JONES BEACH, N.Y. (PIX11) – An 18-year-old was arrested as 300 teenagers descended onto Jones Beach on Thursday during their 'senior skip day,' according to the Nassau County Police Department. Police said Kyle Thomas is accused of showing what appeared to be a gun in his waistband as officers tried to disperse the crowd. Fights broke out between the teenagers, who are students of schools in Nassau County and Queens, according to authorities. More Local News Police said at least four people were injured. In New Jersey, lawmakers are working to crack down on large public fights at area beaches. More than 70 people were arrested after a rowdy Memorial Day weekend in Seaside Heights, according to authorities. The Jones Beach crowd isn't the first 'senior skip day' that has turned violent on Long Island. Police said a teenager was shot on the Long Beach boardwalk last year. More: Latest News from Around the Tri-State Two other teenagers were arrested in the incident and it prompted the beach to restrict access to pass holders only. Thomas is due in court later this month, according to authorities. Erin Pflaumer is a digital content producer from Long Island who has covered both local and national news since 2018. She joined PIX11 in 2023. See more of her work here. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
22 minutes ago
- Yahoo
'They killed him and left him in the neighbor's yard', Augusta event calls for unity in face of gun violence
AUGUSTA, Ga. (WJBF)- June is National Gun Violence Awareness Month and it is to raise awareness for gun violence in the United States. Phyllis Jackson knows first-hand about gun violence. In 2019 Jackson's 22-year-old son was shot and killed. 'My son, Gerald Waldon, was killed here in Augusta, he befriended an individual at work. And that individual, along with three others, came to came to the house, lured my son out of the home, and literally within the same neighborhood, they had planned to kill him. And they did just that. They killed him and left him in the neighbor's yard.' Ever since that tragic event, Jackson has been helping to raise awareness about the danger of guns. RELATED STORY: Witnesses talk about man killed in Walton Acres 'Kids are supposed to be able to be kids. Teenagers are supposed to be able to be teenagers. We can't afford to allow our kids to continue to go to the schools, go to malls, go to the grocery stores and have to worry if our child is going to come home. It's vitally important that we do something about it as a community. And if we're voting someone in in that position that we hold them accountable to do the same.' She hopes the community will come to an event Friday night. An 'Evening of Remembrance and Call to Action' will be held in downtown Augusta. 'This event will show everyone that the community stands together in hard times and good times. And in this event, we are remembering those that have been lost to gun violence. And we want to show those that are affected indirectly that you have a part to play in the rebuilding and standing together as one.' If you plan to attend, wear orange as that is the national color for gun violence awareness. The event will be held at the Jessye Norman Amphitheater beginning at 6pm, click here to 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.